Anyway, these researchers set out to close this particular data gap, and the findings are not pretty.
Women had a 34% increased risk of severe AEs compared with men, […]including a 49% increased risk among those receiving immunotherapy.
Women receiving immunotherapy also had
a 66% increased risk of symptomatic AEs compared with men. Moreover, women were more likely to experience severe hematologic AEs among those receiving chemotherapy and immunotherapy.
This, the paper authors wrote, suggests that “broad-based sex differences exist,” and that studying AEs from immunotherapy in particular “is a priority.”
Obviously GFPs agree, although as Jennifer Lopez so cogently noted* above, it doesn’t necessarily follow that this research will therefore happen